• support@ridge-crown.com

    Send us mail

  • What's New?
  • Home
  • About
  • Shop
  • Services
  • Pharmacist
  • Support
  • FAQs
  • Investors Relations
  • Leadership
  • News

NEWS UPDATE

Commercial Paper Offer Opens 6 July

We are pleased to announce that our Commercial Paper (CP) offer will be available for subscription from 6 July.The investment is available with tenors of 3 months and 6 months and offers tax-free returns.Funds raised through this offer will support Ridge Crown Pharmaceuticals expansion into the United States, enabling us to strengthen our operations and pursue new growth opportunities.We look forward to welcoming both new and existing investors. For further information on subscription details and offer terms, please contact our Investor Relations team.

  • June 1, 2026
Source : Ridge crown media

Investor Withdrawal Update

Ridge Crown Pharmaceuticals Company has released its latest investor withdrawal report, highlighting trends from 2018 to 2025. The report shows a decline in the number of investor withdrawals over time, reflecting growing confidence in the Company's long-term growth strategy. As the Company continues to expand internationally, we remain committed to creating lasting value for our investors. We appreciate the continued trust and support of our investment community. As the Company expands its operations into the United States and introduces new investment opportunities, we remain committed to delivering value, transparency, and sustainable growth for our investors.

  • June 7, 2026
Source : Ridge crown media

Revenue Growth Reaches New Milestone

Our Company is pleased to report continued strong revenue growth, reflecting the success of our long-term business strategy and expanding market presence. Our latest financial performance highlights steady year-on-year growth, with revenue reaching a record high in 2025. This achievement demonstrates our commitment to innovation, operational excellence, and delivering value to our customers and investors. As we continue to expand into new markets, this Company remains focused on building sustainable growth and creating long-term opportunities for our stakeholders.

  • June 19, 2026
Source : Ridge crown media

Growth and Future Perspectives

As the Company continues to build on its strong foundation by pursuing sustainable growth, innovation, and operational excellence. Over the years, we have strengthened our position through strategic investments, improved efficiency, and a continued focus on delivering value to our customers and investors. As part of our long-term vision, we are expanding our presence into the United States, creating new opportunities for business development and international partnerships. This expansion represents an important milestone in our commitment to becoming a globally recognized company. Our goal is to achieve sustainable growth, create long-term shareholder value, and remain a trusted partner for our customers and investors.

  • June 26, 2026
Source : Ridge crown media

DISTRIBUTORS

NATIONWIDE

WORLDWIDE

DELIVERY

24/7

ONLINE-SUPPORT

At Ridge Crown Pharmacy, your pharmacist is always here to answer your questions and give you advice so that you can have peace of mind that you are safely taking the correct prescriptions and doses while avoiding dangerous interactions. Subscribe to Ridge Crown Pharmaceuticals.

Useful Links

  • Home
  • About Us
  • Shop
  • Services
  • Get Support
  • Pharmacist

DISCLAIMER

Ridge Crown Pharmaceuticals is a 503A compounder and does not compound commercially available drugs or agents. Vertisis does not bill nor accept any insurance. Please note all medications require a prescription to be prescribed by a physician or certified licensed health care professional. No items will be dispensed as in-office use or without a doctor's prescription. All price information on any and all materials and dosages are subject to change. While we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied. Users should always seek the advice of a physician with any questions regarding their health or medical conditions. Never disregard, avoid, or delay obtaining medical advice or following the advice of a physician because of something you have seen or read on this Site. The information, opinions, data and statements contained on this website should not be interpreted, acted on or represented as prescribing or providing medical advice. Patients should seek their physician for medical prescriptions, education and health care recommendations.

Ridge Crown Pharmaceuticals is a member of The Medical Agency "SWISSMEDIC, an international organization engaged in the resolution of disputes within the within medical services industry..


Ridge Crown Pharmaceuticals is regulated by the European Medicines Agency (EMA). The mission of the EMA and SWISSMEDIC is to protect patients; maintain fair, orderly, and efficient markets; and facilitate good products into the market. Ridge Crown Pharmaceuticals is a pharmaceutical company that Direct access to over 50 medical markets through one account. Any information contained on this website is provided to you for informational purposes only and should not be regarded as an offer or solicitation of an offer to abuse any medical products or related services that may be referenced here. Ridge Crown Pharmaceuticals is a registered pharmaceutical dealer, a member of the SWISSMEDIC and European Medicines Agency (EMA), European Heads of Medicines Agencies (HMA), European Directorate for the Quality of Medicines & Healthcare(EDQM) and a member of the The International Society for Pharmaceutical Engineering (ISPE), the benefits of which are limited to the activities undertaken by Ridge Crown Pharmaceuticals.
Copyright © 2008 Ridge Crown Pharmaceuticals. All Rights Reserved.
  • About
  • Shop
  • Contact
User from just invested in